Sandoz Gliclazide MR 30 mg

Sandoz Gliclazide MR 30 mg extended-release tablets help manage type 2 diabetes by controlling blood sugar levels. This medication is designed for oral use and is manufactured by Sandoz Canada Incorporated.

Gliclazide MR 30 mg is commonly used to manage type 2 diabetes. It works by helping the pancreas produce more insulin, which helps control blood sugar levels. This medication is typically prescribed as part of a broader diabetes management plan, which may include diet and exercise. Gliclazide MR is designed to release the active ingredient gradually over time, providing extended blood sugar control.

Common effects of Gliclazide MR 30 mg may include lowered blood sugar levels, which can help manage symptoms of diabetes. Some individuals may experience mild side effects such as dizziness, headache, or gastrointestinal discomfort. It's important to monitor blood sugar levels regularly while taking this medication.

Gliclazide MR 30 mg should be handled with care, especially by individuals with a history of liver or kidney issues. It's important to follow the prescribed dosage and not to crush or chew the extended-release tablets. Always consult a healthcare provider before starting or stopping any medication.

Gliclazide MR 30 mg may interact with certain medications, including other diabetes drugs, blood thinners, and some antibiotics. Alcohol consumption should be avoided as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.